Kura Oncology Shares Rally After Oversubscription to Offering

By Rob Curran Shares of Kura Oncology were higher after a strong reception for the clinical-stage biotech company's follow-on offering at a substantial...

Related Keywords

Rob Curran , ,Kura Oncology ,Deerfield Management ,Suvretta Capital ,Leerink Partners ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Cancer Drugs ,Healthcare Life Sciences ,Specialized Drugs Medications ,Corporate Funding ,Corporate Industrial News ,Private Placements ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Kura ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,